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Conclusion: Rigid (PLA) and flexible (Ninjaflex) bolus 
materials provide build-up characteristics within 5% of Solid 
Water. When incorporated into treatment planning 
calculations, planned dose for 3D bolus agrees with OSLD 
measured dose to within 2% on average, and 3D printed bolus 
gives lower variability in the agreement of the delivered to 
planned dose. In summary, 3D printed chestwall bolus may be 
produced in an automated fashion and gives improved 
consistency of delivered dose accuracy compared to standard 
sheet bolus. 
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Purpose or Objective: Mitigating risks in radiotherapy is 
paramount for patient safety. A volumetric modulated arc 
therapy (VMAT) adapted to failure mode and effect analysis 
(FMEA) and implemented through workflow-integrated 
checklists is presented. This work is in line with efforts done 
by organizations to integrate a culture of patient safety into 
radiotherapy processes. 
 
Material and Methods: VMAT is currently being offered to our 
patients using RapidArc®, Eclipse® 11, Aria-11®, and 
TrueBeamTM; all by Varian Medical Systems (Palo Alto, CA). 
All systems went clinical in February 2013. Three months into 
the VMAT program, we realized our operation may be 
optimized by using the new Workflow feature introduced in 
Aria® version 11. Consequently, a workgroup consisting of 2 
physicists, 3 radiation oncologists, one radiation therapist 
and one IT was created to identify modes-of-failure in our 
VMAT planning and preparation process; and to implement a 
workflow that mitigates their risks. A process-centered risk 
analysis for VMAT employing FMEA was performed. Risk 
priority numbers (RPN) for occurrence, severity and 
detection, were assigned for identified modes of failure 
based on a simplified model of the AAPM TG100 scoring. 
FMEA for one task in our VMAT process (Figure 1) is presented 
as example in Table1. Mitigation actions were implemented 
into Aria-11® Workflow via integrated checklists where e-
signatures are enforced. Risk mitigation strategies employing 
redundancy, implementation of related policies-and-
procedures, documentation, and peer-review were hardwired 
into the VMAT process. 
 
Results: A VMAT workflow (Figure 1) was designed and 
included 114 potential-modes-of-failure distributed into 4 
groups: (1) 59 modes recurring redundantly, (2) 3 decision-
type modes forcing re-planning, (3) 33 recurring modes aimed 
for enhancing communication, and (4)19 modes occurring 
only once; some with residual RPN’s necessitating 
implementation of policies-and-procedures. In the 18 months 
period leading up to this study, more than 600 VMAT planning 
and preparation processes were delivered conforming to the 
workflow in Figure 1. No aberrations in treatments occurred. 
Shortcomings in e-chart preparations were virtually 
eliminated. 
 
Conclusion: An adaptation of the VMAT planning and 
preparation process to FMEA using the Aria-11® workflow was 
presented. Risk analysis was performed, and risk mitigation 
was achieved through hardwiring appropriate checklists into 
the VMAT planning tasks. The adaptation to FMEA resulted in 
marked improvements in patient safety, process control and 
process documentation. The presented workflow adaptation 
to FMEA could serve as a reference or model for clinics 
offering VMAT. 
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Purpose or Objective: The National Platform RT Head and 
Neck Cancer (HNC, Landelijk Platform Radiotherapie 
Hoofdhals Tumoren, LPRHHT) is a working party of the Dutch 
Society of Radiation Oncology, and is engaged in regulating 
and improving RT for HNC. One of the objectives of the 
LPRHHT is to evaluate the variation in treatment plan (TP) 
objectives and possibly improve treatment planning by 
increased organ at risk (OAR) sparing and reduction of 
variation between institutes. 
